High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation

Publication | Open Access

DOI Full Paper Access

107

Citations

References

2005

Year

F Baron, Michael B. Maris, Barry E. Storer, Brenda M. Sandmaier, J P Panse, Thomas R. Chauncey, Mohamed L. Sorror, M-T Little, David G. Maloney, Rainer Storb,

Leukemia

Transplant RejectionCell TherapyTransplantationTransplanted Cd34+ CellsImmunologyHematologyHigh DosesAutoimmunityGraft SurvivalBlood TransplantationMedicineCell TransplantationGraft Rejection